This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Walter Cabri
Senior Vice President API Innovation & Development at Fresenius-Kabi


The industrial experience accumulated in more than 30 years, in large (Pharmacia; BMS; Fresenius-kabi), medium size (Sigma-tau & Antibioticos) and small (Indena) companies, ranges from drug discovery (medicinal chemistry & preclinical development) to Process R&D (Chemical, Analytical, Fermentation and Formulation Development) and Regulatory Affairs. 113 publications; 100 Patents and one book.

Agenda Sessions

  • Generic Peptides in the Actual Regulatory Environment: Focus on Synthetic Generic vs. Recombinant RLD